Cardiovascular side effects of small molecule therapies for cancer

Eur Heart J. 2016 Sep 21;37(36):2742-2745. doi: 10.1093/eurheartj/ehw361.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular System / drug effects
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Neoplasms / drug therapy*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • MTOR protein, human
  • Protein-Tyrosine Kinases
  • TOR Serine-Threonine Kinases
  • Mitogen-Activated Protein Kinases